Verdict Medical Devices

AccuStem Sciences acquires licence for lung cancer screening test

AccuStem Sciences has acquired the licence for the microRNA Signature Classifier (MSC) test, developed to aid in lung cancer screening. The post AccuStem Sciences acquires licence for lung cancer screening test appeared first on Medical Device Network.

Mar 19, 2025 - 13:06
 0
AccuStem Sciences acquires licence for lung cancer screening test
AccuStem Sciences has acquired the licence for the microRNA Signature Classifier (MSC) test, developed to aid in lung cancer screening.

The post AccuStem Sciences acquires licence for lung cancer screening test appeared first on Medical Device Network.

Read More

Tags:

Previous Article

Dimension Energy upsizes credit facility to support 3.5GW community solar portfolio

Next Article

Laplace gains funding for transcatheter tricuspid valve replacement trial

Related Posts

Philips secures EU MDR certificate for imaging solution

Philips secures EU MDR certificate for imaging solution

Feb 26, 2025  0

Thermo Fisher introduces Evos S1000 imaging system for spatial tissue proteomics

Thermo Fisher introduces Evos S1000 imaging system for ...

Feb 13, 2025  0

OCT West Coast 2025: Recruitment and regulation still pain points

OCT West Coast 2025: Recruitment and regulation still p...

Feb 20, 2025  0